Sexual Dysfunctions & Paraphilias – Comprehensive Study Notes

Page 1

  • Psychiatry divides sexual topics into: normal sexuality, sexual dysfunctions, paraphilias, and gender dysphoria.
  • Two disorder clusters covered here: sexual dysfunctions (failures in normal response) vs. paraphilias (atypical, often illegal urges).
  • Sexual dysfunction = inability to respond to stimulation or painful sex; ICD-10: inability “to participate in a sexual relationship as he or she would wish”.
  • DSM-5 list begins: male hypoactive sexual desire disorder

Page 2

  • Full DSM-5 list: male hypoactive desire, female sexual interest/arousal, erectile, female orgasmic, delayed ejaculation, premature ejaculation, genito-pelvic pain/penetration, substance/med-induced, other/unspecified.
  • Specify: lifelong vs. acquired, generalized vs. situational, etiology (psychologic, physiologic, mixed).
  • Rule-out: if entirely med/substance, code “due to GMC” or “substance-induced”.
  • Severity coded by patient distress \text{(mild\;|\;moderate\;|\;severe)}.

Page 3

  • Male hypoactive sexual desire = \leq sexual thoughts/desire \geq 6\text{ mo}.
  • Prevalence low overall \approx 2\% ages 16–44, increases to 40\% age 66–74.
  • Causes: defensive inhibition, hostility to partner, poor self-esteem, health, meds, stress.
  • Diagnostic pearl: only pathologic if distressing to patient.

Page 4

  • Sex-history outline (Table 16-1) begins: ID data—age, sex, occupation, relationship status, orientation.

Page 5

  • Current functioning: satisfaction level, specific dysfunctions, onset (lifelong vs. acquired), generalized vs. situational, frequency, libido rating, script of typical encounter, compulsivity screen.

Page 6

  • Childhood section: parental attitudes, nudity rules, sex education sources, early self-stimulation, play “doctor,” reactions/punishment.

Page 7

  • Adolescence: puberty timing, body-image, masturbation pattern, dating history, petting, first orgasm, first coitus, contraception.

Page 8

  • Adult: premarital experiences, contraception, cohabitation, marriage specifics (honeymoon, pregnancy impact, affairs, pornography, conflict areas).
  • Special issues: rape, incest, abuse, STDs, fertility, pregnancies, gender issues, paraphilias.

Page 9

  • DSM vs. ICD comparison table for Male Hypoactive Desire: \geq 6\text{ mo}, distress, specify generalized/situational, mild–severe, lifelong/acquired.

Page 10

  • Table 16-3 Female Sexual Interest/Arousal Disorder: need \geq 3 symptoms most encounters \geq 6\text{ mo}; similar specifiers.

Page 11

  • Conceptual change: desire & arousal merged for women (non-linear response, especially long-term couples).
  • Lab-correlates: testosterone ↓, estrogen ↓, prolactin ↑, thyroxin ↑.
  • Anticholinergic & antihistaminic meds → lubrication ↓.
  • Relationship discord common etiology.

Page 12

  • Male Erectile Disorder (ED): derogatory term “impotence” dropped.
  • Types: lifelong, acquired, situational.
  • Prevalence acquired 10–20\%; chief complaint >50\% of treated men; lifelong rare \approx1\% <35.
  • Red flags organic after 50 yrs; spontaneous or morning erections suggest psychogenic.

Page 13

  • Table 16-4 parallels ED criteria; ICD lumps male ED w/ female arousal disorder.

Page 14

  • Performance anxiety cycle: episodes reinforce fear; anger/communication issues with partner contribute.

Page 15

  • Case vignette “Mr Y” – erectile dysfunction, sadistic fantasies, marital avoidance; illustrates psychodynamic conflict.

Page 16

  • Female Orgasmic Disorder: recurrent delay/absence post adequate arousal; some women not distressed.
  • Lifelong vs. acquired; masturbation orgasms easier than partnered.
  • Prevalence overall \approx30\%; heritability 34–45\%.

Page 17

  • Psychologic factors: pregnancy fear, vagina damage fear, hostility, guilt, loss-of-control anxiety, cultural inhibition; somatic complaints may mimic.

Page 18

  • Delayed Ejaculation: difficulty climaxing with partner \geq 6\text{ mo}.
  • Prevalence \approx5\%; ↑ with SSRI use & high-stimulation internet porn.
  • Severe psychopathology; OCD, ADHD, hostility themes.

Page 19

  • Case vignette: man only ejaculated with two women or cocaine, anger issues, narcissism → combined therapy.

Page 20

  • Premature Ejaculation (PE): DSM timing \leq1\text{ min} vaginal penetration; specifiers mild 30–60\text{ s}, moderate 15–30\text{ s}, severe <15\text{ s}.
  • Prevalence new criteria 1–3\%; physiologic vs. conditioned subtypes; partner/relationship factors.

Page 21

  • Female premature orgasm data sparse; rare epileptogenic focus or SSRI-induced spontaneous orgasms.

Page 22

  • Orgasmic Anhedonia: physical ejaculation w/o pleasure; must rule out lesions; often severe guilt → dissociation; code “other specified sexual dysfunction”.

Page 23

  • Genito-Pelvic Pain/Penetration Disorder (GPPPD) combines prior dyspareunia & vaginismus; any combo of: penetration difficulty, pain, fear, pelvic floor tension.

Page 24

  • Dyspareunia: \approx5\% women; hormonal post-menopause ↑; history sexual trauma common; postpartum transient.
  • Vaginismus: involuntary outer-third spasm; may be complete; strict religion, abuse, medical trauma etiologies.

Page 25

  • Case “Miss B” lifelong GPPPD; fear of penetration; orgasmic via non-coital stimulation.

Page 26

  • Table 16-8 DSM criteria & specifiers for GPPPD.

Page 27

  • Post-coital headache: throbbing occipital/frontal; vascular/tension; classify as “other specified”.

Page 28

  • Sexual Dysfunction due to GMC: 20–50\% ED organic; age >60; tests: nocturnal tumescence, Doppler, hormone panels, invasive studies for surgery candidacy.

Page 29

  • Female dyspareunia organic: surgery 30\% temporary pain; post-menopause mucosa thinning; vestibulitis, interstitial cystitis.
  • Female desire/arousal ↓ after illness, surgery, low testosterone.

Page 30

  • Table 16-9 diseases causing male ED: vascular, neurologic, endocrine, meds, surgery.
  • Retrograde ejaculation = organic (post-surgery, anticholinergics).

Page 31

  • Female orgasmic dysfunction from hypothyroid, DM, hyperprolactin; meds: antihypertensives, stimulants, TCAs, SSRIs, MAOIs.

Page 32

  • Table 16-10 drugs impairing male function: psychotropics, antihypertensives, abused substances; trazodone risk priapism.

Page 33

  • Substance/Medication-Induced Dysfunction: pattern relation to intox/withdrawal or med change; nearly any psych med can affect sex; Dopamine ↑ drive; serotonin ↓.

Page 34

  • Antipsychotics: dopamine blockade → libido ↓, ED, retrograde ejaculation; rare priapism.
  • Antidepressants: anticholinergic delays; SSRIs common anorgasmia; cyproheptadine or methylphenidate antidotes.

Page 35

  • Lithium ↓ hypersexuality; stimulants initially ↑ libido then crash; β-blockers, clonidine, spironolactone, thiazides → ED.

Page 36

  • Alcohol small doses disinhibit, high doses ↓ erection/testosterone; opioids, hallucinogens, cannabis, barbiturates variable effects.

Page 37

  • Treatment overview: traditionally psychodynamic; now combine behavioral, pharmacologic, mechanical.
  • Pharm for ED: PDE-5 inhibitors (sildenafil etc.), phentolamine, alprostadil injections, MUSE; nitrates contraindicated; NAION rare.

Page 38

  • Topical vasoactive creams, female arousal agents (phentolamine gel, flibanserin); SSRIs/TCAs useful for PE; topical anesthetic cream.

Page 39

  • Hormones: testosterone for hypoandrogenism (watch virilization, prostate); estrogen local therapy for atrophy; antiandrogens for compulsive behavior.

Page 40

  • Mechanical: vacuum pump; EROS clitoral suction; penile prostheses (semi-rigid vs. inflatable); vascular bypass surgery select cases.

Page 41

  • Dual-Sex Therapy (Masters & Johnson): couple as treatment unit, sensate focus, communication, anxiety reduction; variations with single therapist.

Page 42

  • Specific techniques: squeeze & stop-start for PE; dilators & physio for vaginismus; masturbation training for anorgasmia; systematic desensitization & mindfulness; group therapy cautions; hypnosis; analytically-oriented sex therapy.

Page 43

  • Paraphilic Disorders: deviant stimuli required for arousal; DSM-5 disorder only if acted on or distressed \geq 6\text{ mo}.

Page 44

  • Exhibitionistic Disorder: expose genitals to stranger; almost all male→female; specifiers target prepubertal, mature, or both.

Page 45

  • Fetishistic Disorder: focus on non-living objects or nongenital parts (partialism); chronic; almost exclusively male.

Page 46

  • Frotteuristic Disorder: rubbing against non-consenting person (crowds); passive isolated males.

Page 47

  • Pedophilic Disorder: victim <14, perpetrator \geq16 & 5 yr older; 95 % heterosexual; co-occur with exhibitionism, voyeurism.

Page 48

  • Sexual Masochism: being humiliated/bound; subtype asphyxiophilia; \approx30\% overlap sadistic fantasies.

Page 49

  • Sexual Sadism: arousal from suffering of another; can escalate to rape/lust murder; onset before 18.

Page 50

  • Voyeuristic Disorder: observing unsuspecting naked/sexual persons; first acts in childhood; legal charge loitering.

Page 51

  • Transvestic Disorder: cross-dressing for arousal; specifiers with fetishism vs. autogynephilia; may progress to gender dysphoria.

Page 52

  • Other Specified Paraphilias: telephone/computer scatologia, necrophilia, partialism (oralism), zoophilia, coprophilia, urophilia, klismaphilia, hypoxyphilia.

Page 53

  • Differential: experimentation vs. compulsive pattern; may link w/ schizophrenia or brain disease.
  • Prognosis poor if early onset, no guilt, polysubstance, multiple paraphilias.

Page 54

  • Treatments: external control (prison, supervision), antiandrogens (medroxyprogesterone, cyproterone), SSRIs, CBT (relapse prevention, victim empathy), psychodynamic insight.
  • Good predictors: single paraphilia, normal IQ, no substances, good adult attachment.

Page 55

  • Epidemiology: rare but repetitive; pedophilia most common legal case; 10–20\% children molested; paraphilia onset
  • Table 16-23 median acts: exhibitionism 50 acts/patient, voyeurism 17 etc.

Page 56

  • Etiology: childhood conditioning, abuse, modeling; psychoanalytic failure of castration/separation anxiety coping; biologic abnormalities (hormones, EEG, chromosomes) in clinical samples.

Page 57

  • Sex Addiction / Compulsivity: not DSM diagnosis; pattern of out-of-control sex seeking, tolerance, withdrawal-like dysphoria; Table 16-24 signs.

Page 58

  • Comorbidity high: substance use \leq80\%, mood/anxiety.
  • Treatment: 12-step (SA, SLAA, SAA), inpatient if danger, SSRIs for compulsive masturbation, medroxyprogesterone ↓ libido, psychotherapy, couples work.

Page 59

  • Normal Sexuality: interplay anatomy, physiology, culture; healthy sex = pleasurable, consensual, non-compulsive.
  • Childhood sexuality recognized (Freud); parental handling differs by sex; critical periods for bonding.

Page 60

  • Four psychosexual factors: sexual identity (biologic), gender identity (felt), sexual orientation, sexual behavior.

Page 61

  • Embryology: default female; SRY, SOX9 → testes; androgen exposure weeks 6–12; disorders of sex development (Table 16-25 list: CAH, Turner XO, Klinefelter XXY, AIS, enzyme defects, hermaphroditism).

Page 62

  • Gender identity usually fixed by 2–3 yrs; gender role learned via reinforcement; incongruence may occur.

Page 63

  • Sexual orientation categories; mention asexual, polysexual; biology vs. environment debate.

Page 64

  • Brain regions: orbitofrontal, anterior cingulate, caudate active during arousal; limbic septum & preoptic area erections; serotonin inhibition.

Page 65

  • Spinal cord reflex centers; penile/clitoral afferents via pudendal nerves.
  • Masters & Johnson cycle: excitement, plateau, orgasm, resolution; vasocongestion & myotonia key.
  • Male & female tables (16-26, 16-27) list specifics; figures show variability.

Page 66

  • Hormones: dopamine, testosterone ↑ desire; serotonin, progesterone, cortisol ↓; oxytocin spikes with orgasm.

Page 67

  • Gender differences: men higher baseline desire; women motives include bonding; subjective vs. physiologic arousal mismatch in women.

Page 68

  • Masturbation universal; infants self-stimulate \approx15–19 months; adolescents use to relieve tension and script adult roles; no evidence causes illness; caution PSA elevation in men.

Page 69

  • First coitus: rites of passage; cultural myths create performance anxiety; contraception underused first time (only \approx50\% women).
  • Elderly sexual activity revived with PDE-5 inhibitors & estrogen creams.

Page 70

  • End of chapter references (selected key studies on Kinsey, Basson female desire, Bancroft, Carnes sex addiction, etc.).